Skip to content

A Randomized Controlled Trial of Exercise Training Among Men With Type 2-diabetes

A Randomized Controlled Trial of Strength Versus Aerobic Exercise Training to Improve Glycemic Control in Men With Type 2-diabetes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00666094
Enrollment
26
Registered
2008-04-24
Start date
2008-08-31
Completion date
2010-03-31
Last updated
2017-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2, Hyperglycemia

Keywords

Type 2-diabetes, exercise therapy, RCT, Norway

Brief summary

To test the hypothesis that there is no difference in change in HbA1C among men with type 2-diabetes after an exercise intervention with strength versus endurance training.

Detailed description

Exercise training is well documented as part of effective treatment for type 2-diabetes patients. Endurance training has been suggested as the most suitable form of exercise. There are reasons to believe that strength training also has a positive effect. However, comparisons of endurance training and strength training regimes are limited. Therefore we randomized 26 men with type 2-diabetes to either an endurance training group or a strength training group. Both groups exercised three sessions per week for three months. The training was supervised.

Interventions

BEHAVIORALEndurance training

supervised endurance training. Three sessions per week in three months.

BEHAVIORALstrength training

Supervised strength training. Three sessions per week in three months.

Sponsors

St. Olavs Hospital
CollaboratorOTHER
Norwegian University of Science and Technology
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
35 Years to 71 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosed with type 2-diabetes * Male, 35-71 years * Managing their diabetes through a lifestyle and/or the drug metformin only * Able to participate in either of the exercise groups

Exclusion criteria

* Symptomatic cardiovascular disease * Uncontrolled hypertension * Physical or cognitive disabilities that will interfere with participating in the exercise regimes. * Trained consistently during the last six months.

Design outcomes

Primary

MeasureTime frame
HbA1C12.01.08

Secondary

MeasureTime frame
body composition, C-peptid, BP, Cholesterol (LDL, HDL), Triglycerides12.01.08

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026